SteadyMed Ltd. (STDY) [Rocket]

In millions, except per share items	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12
	10-K	10-K	10-K	10-K	S-1/A	S-1/A
Total revenues [+]	1.1	1.1	0.9	31.6	6.4	2.7
Royalties					6.4	2.7
Revenue growth	0.0%	22.6%	-97.3%	391.0%	134.5%
Cost of goods sold	-40.9	-54.8	-49.4	0.0	0.0	0.0
Gross profit	41.9	55.9	50.2	31.6	6.4	2.7
Gross margin	3937.6%	5245.2%	5781.2%	100.0%	100.0%	100.0%
Selling, general and administrative [+]	6.9	7.6	5.6	2.9	2.1	1.4
Sales and marketing	1.7	1.9	0.8	0.9	0.5	0.2
General and administrative	5.2	5.6	4.8	2.0	1.6	1.2
Research and development	14.6	20.9	20.0	12.9
EBITDA [+]	21.2	28.0	25.0	16.0	4.4
EBITDA growth	-24.2%	12.0%	56.4%	260.9%	229.5%
EBITDA margin	1993.3%	2630.8%	2879.6%	50.6%	68.9%	49.0%
Depreciation and amortization	0.8	0.6	0.3	0.2	0.1
EBIT [+]	20.4	27.4	24.7	15.8	4.4	1.3
EBIT growth	-25.4%	11.0%	56.2%	263.1%	223.3%
EBIT margin	1918.8%	2572.6%	2840.6%	50.0%	67.6%	49.0%
Interest expense	3.0	0.9	0.1
Interest expense	3.0	0.9	0.1
Other income (expense), net	5.8	-1.0	0.0	3.0	3.4	2.7
Pre-tax income	23.2	25.5	24.6	18.8	7.8	4.1
Income taxes	0.0	-0.4	-0.4	-0.2	-0.1	0.0
Net income	23.2	25.9	25.0	19.0	7.9	4.1
Net margin	2178.9%	2429.0%	2873.5%	60.3%	122.1%	148.6%

Basic EPS [+]	$0.95	$1.59	$2.36	$37.93
Growth	-40.3%	-32.5%	-93.8%
Diluted EPS [+]	$0.95	$1.59	$2.36	$37.93
Growth	-40.3%	-32.5%	-93.8%

Shares outstanding (basic) [+]	24.4	16.3	10.6	0.5
Growth	50.2%	53.4%	2010.3%
Shares outstanding (diluted) [+]	24.4	16.3	10.6	0.5
Growth	50.2%	53.4%	2010.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.